Progesterone Receptor Negative Active Not Recruiting Phase 3 Trials for Bevacizumab (DB00112)

IndicationStatusPhase
DBCOND0038639 (Progesterone Receptor Negative)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00785291Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast CancerTreatment